[Needs of cost-effectivity analysis for the optimization and rationalization of expense in new drugs].
Soto Alvarez
Javier
J
D003362:Cost-Benefit Analysis; D016527:Drug Costs; D004358:Drug Therapy / Q000191:economics*; D005102:Health Expenditures; D006296:Health Services / Q000191:economics*; D006801:Humans; D013030:Spain